Most Recent

image: Editing Genomes to Record Cellular Histories

Editing Genomes to Record Cellular Histories

By Ruth Williams | May 26, 2016

Researchers harness the power of genome editing to track cell lineages throughout zebrafish development.

0 Comments

A Congressional investigation indicates that the National Football League may have sought to steer millions of dollars in National Institutes of Health funding away from one of its critics.

0 Comments

image: Embryo Watch

Embryo Watch

By Jef Akst | May 5, 2016

A new culture system allows researchers to track the development of human embryos in vitro for nearly two weeks.

1 Comment

image: Cellular Pruning Follows Adult Neurogenesis

Cellular Pruning Follows Adult Neurogenesis

By Kerry Grens | May 2, 2016

Newly formed neurons in the adult mouse brain oversprout and get cut back.

0 Comments

image: Observing the Nuclear Pore

Observing the Nuclear Pore

By Tanya Lewis | May 2, 2016

Scientists visualize nuclear pore complexes for the first time, using high-speed atomic force microscopy.

1 Comment

image: Animal Magnetism

Animal Magnetism

By Catherine Offord | May 1, 2016

A photosensitive protein behind the retinas of cockroaches plays a role in light-dependent, directional magnetosensitivity.

0 Comments

image: Fuchs on the Future

Fuchs on the Future

By The Scientist Staff | May 1, 2016

Rockefeller University researcher Elaine Fuchs on being a woman in science and her contributions to the burgeoning field of reverse genetics

0 Comments

image: Instant Messaging

Instant Messaging

By Catherine Offord | May 1, 2016

An alternative route to sparking cell signals involves hook-ups between transmembrane and soluble ligands.

0 Comments

image: More Than Skin Deep

More Than Skin Deep

By Anna Azvolinsky | May 1, 2016

Elaine Fuchs has worked on adult stem cells since before they were so named, figuring out how multipotent epidermal cells renew or turn into skin or hair follicles.

1 Comment

image: Another Fatal-Disease Drug in Limbo

Another Fatal-Disease Drug in Limbo

By Jef Akst | April 26, 2016

A federal advisory panel votes against Sarepta Therapeutics’s treatment for Duchenne muscular dystrophy.

0 Comments

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. Could a Dose of Sunshine Make You Smarter?
  3. Prevalent Form of Childhood Leukemia May Be Preventable
  4. Arizona Moves to Alter Wording About Evolution in Education